Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

804 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.
Hamilton BK, Cutler C, Divine C, Juckett M, LeMaistre C, Stewart S, Wilder J, Horowitz M, Khera N, Burns LJ. Hamilton BK, et al. Among authors: cutler c. Transplant Cell Ther. 2022 Aug;28(8):419-425. doi: 10.1016/j.jtct.2022.05.002. Epub 2022 May 9. Transplant Cell Ther. 2022. PMID: 35550441 Free PMC article.
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L, Harrison MJ, Ho V, Alyea E, Lee SJ, Soiffer R, Sonis S, Antin JH. Cutler C, et al. Biol Blood Marrow Transplant. 2005 May;11(5):383-8. doi: 10.1016/j.bbmt.2005.02.006. Biol Blood Marrow Transplant. 2005. PMID: 15846292 Free article.
Chronic graft-versus-host disease.
Cutler C, Antin JH. Cutler C, et al. Curr Opin Oncol. 2006 Mar;18(2):126-31. doi: 10.1097/01.cco.0000208784.07195.84. Curr Opin Oncol. 2006. PMID: 16462180 Review.
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Brown JR, Kim HT, Li S, Stephans K, Fisher DC, Cutler C, Ho V, Lee SJ, Milford EL, Ritz J, Antin JH, Soiffer RJ, Gribben JG, Alyea EP. Brown JR, et al. Among authors: cutler c. Biol Blood Marrow Transplant. 2006 Oct;12(10):1056-64. doi: 10.1016/j.bbmt.2006.06.004. Biol Blood Marrow Transplant. 2006. PMID: 17084369 Free article.
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Alyea EP, Li S, Kim HT, Cutler C, Ho V, Soiffer RJ, Antin JH. Alyea EP, et al. Among authors: cutler c. Biol Blood Marrow Transplant. 2008 Aug;14(8):920-6. doi: 10.1016/j.bbmt.2008.05.024. Biol Blood Marrow Transplant. 2008. PMID: 18640576 Free PMC article. Clinical Trial.
804 results